The effect of Lixisenatide on triacylglycerol and glucose metabolism in patients with type 2 diabetes

Trial Profile

The effect of Lixisenatide on triacylglycerol and glucose metabolism in patients with type 2 diabetes

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2017

At a glance

  • Drugs Lixisenatide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 13 Jun 2017 Results of effects of lixisenatide on postprandial lipoprotein kinetics (n=8) presented at the 77th Annual Scientific Sessions of the American Diabetes Association
    • 13 Jun 2017 Results assessing action of lixisenatide on mixed meal disposition presented at the 77th Annual Scientific Sessions of the American Diabetes Association
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top